Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Paderborn

59 clinical trials in Paderborn, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Paderborn at a glance
59
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

59 trials in Paderborn

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:GermanyGermany
  • Participants:65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:F. Hoffmann-La Roche AG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:University Of Cologne
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Azd8205
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Epcoritamab
  • Sponsor:Universitaet Muenster
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Merck Sharp & Dohme LLC
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Inavolisib
  • Sponsor:F. Hoffmann-La Roche AG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Obinutuzumab
  • Sponsor:University Of Cologne
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:AGO Research GmbH

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Paderborn

What the registry says about research in the country

01 Breast Cancer Research

Innovative clinical trials exploring treatments for various types of breast cancer, including HR-positive, HER2-negative, and triple-negative subtypes. Studies evaluate combination therapies and novel approaches in both early-stage and advanced disease settings.

  • Endocrine therapy combinations
  • Immunotherapy approaches
  • Targeted treatments

Multiple trials focusing on improving survival rates and treatment outcomes for breast cancer patients.

02 Hematologic Malignancies

Comprehensive research into blood cancers, with a focus on chronic lymphocytic leukemia, multiple myeloma, and various lymphomas. Studies examine novel drug combinations and targeted therapies.

  • Innovative drug combinations
  • Maintenance therapies
  • Treatment-naive approaches

Trials aim to improve treatment responses and patient outcomes in various blood cancers.

03 Gastrointestinal Oncology

Studies investigating treatments for colon cancer and other gastrointestinal malignancies. Research focuses on both early-stage and advanced disease, exploring pre-operative and post-operative treatment strategies.

  • Preoperative chemotherapy
  • Surgical approaches
  • Adjuvant therapy optimization

Research aims to improve surgical outcomes and treatment effectiveness in gastrointestinal cancers.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.